Molecure S.A.

Informe acción WSE:MOC

Capitalización de mercado: zł244.5m

Molecure Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Marcin Szumowski

Chief Executive Officer (CEO)

zł548.0k

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO0.7%
Permanencia media de la dirección3.3yrs
Promedio de permanencia en la Junta Directiva2.6yrs

Actualizaciones recientes de la dirección

Recent updates

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Apr 20
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Dec 01
We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Jul 07
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Mar 10
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Aug 16
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Nov 04
OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Feb 24
Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

Jan 02
Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

CEO

Marcin Szumowski

no data

Permanencia

zł548,043

Compensación

Mr. Marcin Jan Szumowski, Ph D., is employed at Life Science Innovations Fund. He has been Chief Executive Officer and President of the Management Board at Molecure S.A. (formerly known as OncoArendi Thera...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Marcin Szumowski
Co-Founderno datazł548.04k0.70%
PLN 1.7m
Adam Golebiowski
Co-Founder & VP of Research Chemistry12.3yrszł500.00k3.01%
PLN 7.4m
Slawomir Broniarek
CFO & Member of the Management Boardno datazł414.20k0.20%
PLN 501.0k
Zbigniew Zaslona
Chief Scientific Officer & Member of Management Board2.3yrszł376.64k0.11%
PLN 274.3k
Agnieszka Rajczuk-Szczepanska
Member of Management Board & HR Director4.3yrszł345.44k0.034%
PLN 84.2k
Jacek Olczak
Co-Founder & Head of Medicinal Chemistryno datasin datossin datos
Samson Fung
Chief Medical Officer & Member of Management Board1.3yrssin datossin datos
Magdalena Tyszkiewicz
Head of CMC4.3yrssin datossin datos
Marta Borkowska
Director of the Management Board Office2.3yrssin datossin datos

3.3yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de MOC se considera experimentado (3.3 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Reynold A. Panettieri
Member of Scientific Advisory Boardno datasin datossin datos
Bart Lambrecht
Member of Scientific Advisory Boardno datasin datossin datos
Jakub Golab
Member of Scientific Advisory Boardno datasin datossin datos
Tomasz Piec
Vice Chairman of the Supervisory Board4.3yrszł140.98ksin datos
Douglas Hay
Member of Scientific Advisory Boardno datasin datossin datos
Rafal Kaminski
Member of the Supervisory Board2.3yrszł63.46ksin datos
Paul Van Der Horst
Member of Supervisory Board2.3yrszł117.62k0.059%
PLN 145.2k
Mariusz Gromek
Member of Supervisory Boardno datazł112.78ksin datos
Piotr Zólkiewicz
Independent Chairman of Supervisory Board3.3yrszł197.37ksin datos
Rafal Krenke
Member of Scientific Advisory Boardno datasin datossin datos
Bruce Conway
Member of Scientific Advisory Boardno datasin datossin datos
Nancy Van Osselaer
Member of the Supervisory Board & Member of Scientific Advisory Board2.6yrszł117.62ksin datos

2.6yrs

Permanencia media

Junta con experiencia: La junta directiva de MOC no se considera experimentada (2.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.